Acamprol 333mg
| SKU | 2 |
|---|---|
| Generic For | Campral |
| Strength | 333mg |
| Active Ingredient | Acamprosate |
| Pack Size | Qty | Price Per Pill or Unit | Price | Cart | |
|---|---|---|---|---|---|
| 30 Tablet/s | US$ 0.48 | US$ 14.43 | |||
|
|||||
| 60 Tablet/s | US$ 0.48 | US$ 28.88 | |||
|
|||||
| 90 Tablet/s | US$ 0.48 | US$ 43.32 | |||
|
|||||
Acamprol 333mg (Acamprosate) – Affordable Campral Alternative
Acamprol 333 mg is an oral prescription medication primarily used to support long-term recovery in people with alcohol dependence. It is most effective when started after a person has stopped drinking alcohol and is used alongside counselling, behavioural therapy, and a structured recovery programme. Rather than causing an unpleasant reaction to alcohol, Acamprol reduces cravings and improves the chances of maintaining abstinence.
Manufacturer Details: Acamprol 333 mg is manufactured by Sun Pharmaceutical Industries Ltd., one of India's leading pharmaceutical companies with a global presence in more than 100 countries.
Acamprosate, the active ingredient & its mode of action
The active ingredient in Acamprol 333 mg is Acamprosate calcium, which acts on neurotransmitter systems within the brain that become imbalanced due to chronic alcohol exposure. Long-term alcohol consumption alters the normal balance between excitatory and inhibitory brain signals, particularly involving glutamate and gamma-aminobutyric acid (GABA). Even after alcohol use is stopped, these neurotransmitter systems remain dysregulated, contributing to cravings, anxiety, sleep disturbances, and a heightened risk of relapse. Acamprosate helps restore this disrupted balance by modulating glutamatergic neurotransmission while supporting normal GABA activity. Although its precise mechanism is not completely understood, the medicine is believed to reduce excessive neuronal excitation that occurs during prolonged alcohol withdrawal. By stabilising brain function, Acamprol decreases the psychological discomfort associated with abstinence and helps patients maintain long-term sobriety. It does not produce intoxication, dependence, or withdrawal symptoms and has no rewarding effects, making it suitable for extended treatment under medical supervision.
Acamprol 333 mg Benefits and Uses
Acamprol 333 mg is prescribed as part of a comprehensive alcohol dependence treatment programme and offers several clinical benefits.
- Its primary benefit is reducing the risk of relapse in individuals who have already stopped drinking. By decreasing alcohol cravings and easing the emotional discomfort associated with abstinence, it supports long-term recovery and increases the likelihood of maintaining sobriety.
- This medication is intended for adults who have already undergone alcohol detoxification and are committed to remaining alcohol-free.
- Unlike medications that discourage drinking by causing unpleasant physical reactions, Acamprosate works by helping normalise brain chemistry. This allows patients to focus on behavioural therapy, counselling, and lifestyle modifications without experiencing medication-induced sedation or intoxication.
- Because it does not produce sedation or euphoria, it has a low potential for abuse and is considered a valuable option for long-term maintenance therapy.
- Clinical studies have shown that individuals receiving Acamprosate alongside counselling generally achieve higher rates of continuous abstinence compared with counselling alone. The medicine is particularly beneficial for motivated individuals who have completed alcohol detoxification and remain committed to avoiding alcohol. Regular follow-up appointments and participation in rehabilitation programmes further enhance treatment success.
Acamprol is not a cure for alcohol use disorder, but it can significantly improve treatment outcomes when combined with ongoing psychosocial support.
Brand Campral vs Generic Acamprosate
Campral is the original branded formulation of Acamprosate calcium, while Acamprol 333 mg is a generic equivalent containing the same active ingredient in the same therapeutic strength. Both medicines are intended to support abstinence in patients recovering from alcohol dependence and work through identical pharmacological mechanisms. When approved by regulatory authorities, generic medicines must demonstrate bioequivalence, meaning they deliver comparable amounts of the active ingredient into the bloodstream and provide similar clinical effectiveness and safety. The most notable differences are branding, packaging, manufacturer, and cost.
A convenient way to buy medicine online
Choose a licensed and reputable pharmacy that dispenses genuine prescription medicines at an affordable rate. In comprehensive alcohol dependence management, physicians may prescribe alternative alcohol & drug treatment medications such as Naltrexone (Naltima 50mg, Nodict 50mg) or Disulfiram (Esperal 250mg) depending on individual medical history, treatment goals, liver function, and relapse risk. You can rely on PremiumRxDrugs to get genuine medicine supplies at affordable prices.
Important safety considerations associated with Acamprosate
Before starting Acamprol 333 mg or Campral, inform your healthcare provider about your complete medical history, especially if you have kidney disease, depression, suicidal thoughts, or other psychiatric disorders. The medicine is generally not recommended in patients with severe renal impairment because Acamprosate is eliminated primarily through the kidneys. Dose adjustments may be necessary for individuals with moderate kidney dysfunction. Continue attending counselling sessions and support programmes while taking Acamprol, as medication alone may not be sufficient for successful recovery. If alcohol is consumed during treatment, continue taking the medication unless advised otherwise by your physician, but seek medical guidance promptly.
Pregnant or breastfeeding women should use this medicine only if the anticipated benefits outweigh potential risks. Inform your doctor about all prescription medicines, over-the-counter products, vitamins, and herbal supplements to minimise the possibility of drug interactions. Regular medical reviews help monitor treatment response, adherence, and overall mental wellbeing throughout therapy.
Potential side effects of Acamprosate
Like all medicines, Acamprol 333 mg or Campral may cause side effects, although many individuals tolerate treatment well. The most commonly reported effects include diarrhoea, nausea, abdominal discomfort, gas, loss of appetite, headache, dizziness, dry mouth, itching, excessive sweating, and mild skin rash. These symptoms are usually temporary and often improve as the body adjusts to therapy.
Some patients may experience anxiety, insomnia, mood changes, or depressive symptoms, particularly during early recovery from alcohol dependence. Because alcohol withdrawal itself can affect mental health, any worsening depression, unusual behavioural changes, or thoughts of self-harm require immediate medical attention. Severe allergic reactions, including facial swelling, breathing difficulty, or widespread rash, are uncommon but require urgent emergency care. Maintaining adequate hydration and following the prescribed dosage schedule may help improve treatment tolerability. Always report persistent or troublesome side effects to your healthcare provider rather than discontinuing the medication independently.
How to Acamprol 333mg use?
Proper use and dosage of Acamprosate
Take Acamprosate 333 mg or Campral exactly as prescribed by your physician. The tablets are usually swallowed whole with water and may be taken with or without food, although taking them consistently with meals may improve adherence. Treatment should begin only after alcohol detoxification has been completed and abstinence has been achieved. Continue taking the medication even if you experience occasional cravings, and do not discontinue treatment without consulting your doctor. Missing doses may reduce treatment effectiveness, so establish a regular dosing schedule to maintain consistent therapeutic levels.
What is Acamprol 333mg used for?
Acamprol 333mg contains acamprosate calcium 333mg — an anti-craving medication for alcohol use disorder (AUD). It is used to maintain alcohol abstinence in patients who have already achieved abstinence (detoxification) and are receiving concurrent psychosocial support. Acamprosate does not reduce withdrawal symptoms — it is started after detoxification is complete. Mechanism: acamprosate modulates glutamate and GABA neurotransmitter systems in the brain, which are disrupted by chronic alcohol use. It restores neurochemical balance in the reward and craving centres, reducing the unpleasant symptoms of post-acute withdrawal (anxiety, insomnia, restlessness, dysphoria) that drive relapse. It is most effective when combined with counselling, support groups, and behavioural therapy as part of a comprehensive AUD treatment programme.
How should Acamprol 333mg be taken for alcohol abstinence maintenance?
Take Acamprol 333mg as follows: standard dose — 666mg (two 333mg tablets) three times daily with meals (morning, midday, and evening). For patients <60kg: dose may be reduced to 333mg in the morning and 666mg at midday and evening. Start acamprosate as soon as alcohol detoxification is complete — ideally within a few days of achieving abstinence. Swallow tablets whole with water. Continue taking even if a relapse (drinking epiSodiume) occurs — acamprosate's benefit persists with continued therapy. Recommended treatment duration: at least 12 months; many guidelines recommend continuing for 1–2 years as relapse risk remains elevated. Take at consistent times each day for reliable blood levels. Renal dose adjustment is needed for reduced kidney function.
What is the difference between acamprosate and naltrexone for alcohol use disorder?
Acamprosate (Acamprol) and naltrexone are the two most evidence-based pharmacotherapies for alcohol use disorder maintenance. Acamprosate mechanism: modulates glutamate/GABA systems, reducing post-acute withdrawal dysphoria and craving. Naltrexone mechanism: opioid receptor antagonist — blocks alcohol's euphoric reward effect (reduces positive reinforcement of drinking). Key differences: acamprosate is most effective for maintaining abstinence in patients motivated to remain completely abstinent; naltrexone is more effective for reducing heavy drinking days and craving reduction — suitable for patients using a 'harm reduction' (reduced drinking) approach. Acamprosate requires normal kidney function (renally excreted — avoid in severe renal impairment); naltrexone requires normal liver function (hepatically metabolised — avoid in significant liver disease). Both are FDA-approved; choice depends on patient goals and organ function.
What drug interactions apply to Acamprol 333mg?
Acamprosate has minimal drug interactions — it is not significantly metabolised by CYP enzymes (eliminated renally unchanged) and has low protein binding. Alcohol: acamprosate does not cause a disulfiram-like reaction if alcohol is consumed — patients can continue treatment through relapses without adverse interaction (unlike disulfiram, which causes a severe reaction with alcohol). Tetracyclines and antacids: concomitant use of antacids containing aluminium, magnesium, or calcium may slightly reduce acamprosate absorption — separate by at least 2 hours. Naltrexone: can be combined with acamprosate (additive benefits in some studies); no pharmacokinetic interaction. No clinically significant interactions with common psychiatric medications (antidepressants, antipsychotics, benzodiazepines) used in AUD co-morbidity treatment.
Is Acamprol 333mg safe in patients with liver disease from alcoholism?
Acamprosate is safe in liver disease — unlike naltrexone (which is hepatotoxic and requires caution in liver disease). Acamprosate is excreted renally unchanged without significant hepatic metabolism — patients with alcoholic liver disease (common in AUD patients) can safely use acamprosate without dose adjustment based solely on liver impairment. Renal function is the critical consideration: acamprosate is renally cleared — dose reduction or avoidance is required in moderate-to-severe renal impairment (creatinine clearance <30ml/min). Before starting acamprosate: check renal function (eGFR/creatinine) alongside standard liver function assessment. This renal-clearance-without-hepatic-metabolism profile makes acamprosate the preferred pharmacotherapy when hepatic impairment is the concern.
Is Acamprol 333mg equivalent to Campral 333mg?
Yes. Acamprol 333mg and branded Campral EC 333mg both contain acamprosate calcium 333mg in equivalent enteric-coated tablet formulations. Acamprol is the generic alternative providing the same evidence-based alcohol abstinence maintenance therapy at significantly lower cost. PremiumRxDrugs.com stocks authentic manufacturer-sourced Acamprol 333mg verified for quality and bioequivalence.
Can I order Acamprol 333mg from PremiumRxDrugs for international delivery?
Yes. PremiumRxDrugs.com ships Acamprol 333mg to the USA, UK, Australia, and many other countries. Our genuine manufacturer-verified acamprosate tablets, competitive pricing, and free worldwide shipping on qualifying orders make us a reliable international source for alcohol abstinence medication.
What side effects does Acamprol 333mg cause?
Very common: diarrhoea (up to 30% of patients — the most common reason for discontinuation); nausea and abdominal discomfort. GI side effects are usually mild and diminish after the first 1–2 weeks. Other common effects: headache, flatulence, pruritus (itching — particularly on the skin). Psychiatric effects: depression, anxiety (may reflect underlying post-acute withdrawal rather than direct drug effect — monitor carefully). Suicidality: patients with AUD have elevated suicide risk regardless of medication — monitor for depression and suicidal ideation during treatment. Very rare: allergic reactions including anaphylaxis. Sexual dysfunction reported rarely. Acamprosate has no abuse potential, no withdrawal syndrome on stopping, and no known hepatotoxicity — a favourable safety profile for long-term use.
How effective is Acamprol 333mg for preventing alcohol relapse?
Clinical trial evidence: acamprosate approximately doubles abstinence rates compared to placebo over 12 months — from approximately 20–25% (placebo) to 40–45% (acamprosate + psychosocial support). Meta-analyses (Cochrane reviews) confirm acamprosate's efficacy for extending abstinence and reducing relapse risk. Predictors of better response: strong motivation to remain abstinent; concurrent psychosocial support (12-step programmes, CBT, motivational interviewing); good medication adherence; absence of significant psychiatric comorbidity. Effectiveness in practice: combination treatment (acamprosate + psychosocial support) consistently outperforms either treatment alone — medication is not a substitute for counselling and social support. Real-world abstinence rates are lower than clinical trial rates due to variable adherence.
Should Acamprol 333mg be continued during a relapse?
Yes — acamprosate should be continued even if the patient experiences a relapse (drinking epiSodiume) during treatment. This is a critical distinction from disulfiram (which causes severe adverse reactions with alcohol) and from medication discontinuation being equated with treatment failure. Rationale: acamprosate has no adverse interaction with alcohol — there is no safety concern in continuing during a relapse. A single relapse is expected in AUD treatment (approximately 70% of patients relapse at some point) and does not represent treatment failure — it is part of the recovery process. Stopping acamprosate at first relapse removes the pharmacological support precisely when it is needed most. Encourage the patient to recommit to abstinence, intensify psychosocial support, and continue acamprosate throughout the recovery journey.
Is Acamprol 333mg safe in pregnancy for women with alcohol use disorder?
Acamprosate is FDA Category C in pregnancy — animal studies show some developmental toxicity at high doses; human data is very limited. In pregnant women with AUD, the risks of continued alcohol use significantly outweigh the theoretical risks of acamprosate therapy. However: acamprosate is not the pharmacotherapy of choice for AUD in pregnancy — behavioural therapies, psychosocial support, and motivational interviewing are first-line. If pharmacotherapy is required, careful specialist assessment is needed. Naltrexone (also Category C) has similar pregnancy data limitations. For alcohol detoxification in pregnancy (acute withdrawal): benzodiazepines under medical supervision are used, then psychosocial approaches. Discuss risk-benefit of any pharmacotherapy for AUD with the obstetrician and addiction specialist.
Login
Sign Up
Login
Sign Up